Peroxisome proliferator-activated receptor-α activation and excess energy burning in hepatocarcinogenesis

Biochimie

Volumn 98, Issue 1, 2014, Pages 63-74

  Misra, Parimal ^a   Reddy, Janardan K ^b  

^a INSTITUTE OF LIFE SCIENCES   (India)

^b NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Energy combustion; Fatty acid oxidation; Liver tumors; Med1; Oxidative stress; PPAR

Indexed keywords

ACOX1 PROTEIN; DNA; FATTY ACID; HYDROGEN PEROXIDE; MEDIATOR COMPLEX; MEMBRANE PROTEIN; MICRORNA; PEROXISOME PROLIFERATOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; REACTIVE OXYGEN METABOLITE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR MED1; UNCLASSIFIED DRUG;

CANCER RISK; CELL PROLIFERATION; DNA DAMAGE; ENDOPLASMIC RETICULUM STRESS; ENERGY BURNING; ENERGY METABOLISM; ENZYME DEGRADATION; FATTY ACID OMEGA OXIDATION; FATTY ACID OXIDATION; GENE INACTIVATION; HUMAN; INFLAMMATION; LIVER CANCER; LIVER CARCINOGENESIS; LIVER CELL; LIVER TUMOR; NONHUMAN; OXIDATIVE STRESS; PEROXISOME; REVIEW; SIGNAL TRANSDUCTION;

RODENTIA;

ENERGY COMBUSTION; FATTY ACID OXIDATION; LIVER TUMORS; MED1; OXIDATIVE STRESS; PPARΑ;

ANIMALS; CELL PROLIFERATION; ENERGY METABOLISM; FATTY ACIDS; LIVER; LIVER NEOPLASMS; MEDIATOR COMPLEX SUBUNIT 1; MICE; MICE, KNOCKOUT; MICRORNAS; OXIDATION-REDUCTION; OXIDATIVE STRESS; PEROXISOME PROLIFERATORS; PEROXISOMES; PPAR ALPHA;

EID: 84895168540     PISSN: 03009084     EISSN: 61831638     Source Type: Journal    
DOI: 10.1016/j.biochi.2013.11.011     Document Type: Short Survey

References (111)

1. B.A. Swinburn, G. Sacks, K.D. Hall, K. McPherson, D.T. Finegood, M.L. Moodie, and S.L. Gortmaker The global obesity pandemic: shaped by global drivers and local environments Lancet 378 2011 804 814
2. D.M. Nguyen, and H.B. El-Serag The epidemiology of obesity Gastroenterol. Clin. North Am. 39 2010 1 7
3. V.G. Agopian, F.M. Kaldas, J.C. Hong, M. Whittaker, C. Holt, A. Rana, A. Zarrinpar, H. Petrowsky, D. Farmer, H. Yersiz, V. Xia, J.R. Hiatt, and R.W. Busuttil Liver transplantation for nonalcoholic steatohepatitis: the new epidemic Ann. Surg. 256 2012 624 633
4. J.C. Cohen, J.D. Horton, and H.H. Hobbs Human fatty liver disease: old questions and new insights Science 332 2011 1519 1523
5. A. Vluggens, and J.K. Reddy Nuclear receptors and transcription factors in the development of fatty liver disease Curr. Drug Metab. 13 2012 1422 1435
6. J.K. Reddy, and M.S. Rao Lipid metabolism and liver inflammation. II. Fatty liver disease and fatty acid oxidation Am. J. Physiol. Gastrointest. Liver Physiol. 290 2006 G852 G858
7. J.M. Friedman, and J.L. Halaas Leptin and the regulation of body weight in mammals Nature 395 1998 763 770
8. J. Huang, Y. Jia, T. Fu, N. Viswakarma, L. Bai, M.S. Rao, Y. Zhu, J. Borensztajn, and J.K. Reddy Sustained activation of PPARalpha by endogenous ligands increases hepatic fatty acid oxidation and prevents obesity in ob/ob mice FASEB J. 26 2012 628 638
9. C.P. Day, and O.F. James Hepatic steatosis: innocent bystander or guilty party? Hepatology 27 1998 1463 1466
10. J. Huang, N. Viswakarma, S. Yu, Y. Jia, L. Bai, A. Vluggens, M. Cherkaoui-Malki, M. Khan, I. Singh, G. Yang, M.S. Rao, J. Borensztajn, and J.K. Reddy Progressive endoplasmic reticulum stress contributes to hepatocarcinogenesis in fatty acyl-CoA oxidase 1-deficient mice Am. J. Pathol. 179 2011 703 713
11. Y. Miyaoka, and A. Miyajima To divide or not to divide: revisiting liver regeneration Cell Div. 8 2013 8
12. J.K. Reddy, and T.P. Krishnakantha Hepatic peroxisome proliferation: induction by two novel compounds structurally unrelated to clofibrate Science 190 1975 787 789
13. J.K. Reddy, and N.D. Lalwai Carcinogenesis by hepatic peroxisome proliferators: evaluation of the risk of hypolipidemic drugs and industrial plasticizers to humans Crit. Rev. Toxicol. 12 1983 1 58
14. J.K. Reddy, and M. Sambasiva Rao Peroxisome proliferators and cancer: mechanisms and implications Trends Pharmacol. Sci. 7 1986 438 443
15. M.S. Rao, and J.K. Reddy Peroxisome proliferation and hepatocarcinogenesis Carcinogenesis 8 1987 631 636
16. J.K. Reddy, S.K. Goel, M.R. Nemali, J.J. Carrino, T.G. Laffler, M.K. Reddy, S.J. Sperbeck, T. Osumi, T. Hashimoto, and N.D. Lalwani et al. Transcription regulation of peroxisomal fatty acyl-CoA oxidase and enoyl-CoA hydratase/3-hydroxyacyl-CoA dehydrogenase in rat liver by peroxisome proliferators Proc. Natl. Acad. Sci. U. S. A. 83 1986 1747 1751
17. I. Issemann, and S. Green Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators Nature 347 1990 645 650
18. S.S. Lee, T. Pineau, J. Drago, E.J. Lee, J.W. Owens, D.L. Kroetz, P.M. Fernandez-Salguero, H. Westphal, and F.J. Gonzalez Targeted disruption of the alpha isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators Mol. Cell. Biol. 15 1995 3012 3022
19. S.R. Pyper, N. Viswakarma, S. Yu, and J.K. Reddy PPARalpha: energy combustion, hypolipidemia, inflammation and cancer Nucl. Recept. Signaling 8 2010 e002
20. J.K. Reddy, S. Rao, and D.E. Moody Hepatocellular carcinomas in acatalasemic mice treated with nafenopin, a hypolipidemic peroxisome proliferator Cancer Res. 36 1976 1211 1217
21. J.K. Reddy, D.L. Azarnoff, and C.E. Hignite Hypolipidaemic hepatic peroxisome proliferators form a novel class of chemical carcinogens Nature 283 1980 397 398
22. A.V. Yeldandi, M.S. Rao, and J.K. Reddy Hydrogen peroxide generation in peroxisome proliferator-induced oncogenesis Mutat. Res. 448 2000 159 177
23. C. De Duve, and P. Baudhuin Peroxisomes (microbodies and related particles) Physiol. Rev. 46 1966 323 357
24. J.K. Reddy, and T. Hashimoto Peroxisomal beta-oxidation and peroxisome proliferator-activated receptor alpha: an adaptive metabolic system Annu. Rev. Nutr. 21 2001 193 230
25. L.M. Sandalio, M. Rodriguez-Serrano, M.C. Romero-Puertas, and L.A. Del Rio Role of peroxisomes as a source of reactive oxygen species (ROS) signaling molecules Subcell. Biochem. 69 2013 231 255
26. J.K. Reddy Peroxisome proliferators and peroxisome proliferator-activated receptor alpha: biotic and xenobiotic sensing Am. J. Pathol. 164 2004 2305 2321
27. M. Schrader, and H.D. Fahimi Peroxisomes and oxidative stress Biochim. Biophys. Acta 1763 2006 1755 1766
28. E. Dixit, S. Boulant, Y. Zhang, A.S. Lee, C. Odendall, B. Shum, N. Hacohen, Z.J. Chen, S.P. Whelan, M. Fransen, M.L. Nibert, G. Superti-Furga, and J.C. Kagan Peroxisomes are signaling platforms for antiviral innate immunity Cell 141 2010 668 681
29. F. Fanelli, S. Sepe, M. D'Amelio, C. Bernardi, L. Cristiano, A. Cimini, F. Cecconi, M.P. Ceru, and S. Moreno Age-dependent roles of peroxisomes in the hippocampus of a transgenic mouse model of Alzheimer's disease Mol. Neurodegener. 8 2013 8
30. D.E. Moody, and J.K. Reddy The hepatic effects of hypolipidemic drugs (clofibrate, nafenopin, tibric acid, and Wy-14,643) on hepatic peroxisomes and peroxisome-associated enzymes Am. J. Pathol. 90 1978 435 446
31. D.E. Moody, and J.K. Reddy Hepatic peroxisome (microbody) proliferation in rats fed plasticizers and related compounds Toxicol. Appl. Pharmacol. 45 1978 497 504
32. J. Ashby, A. Brady, C.R. Elcombe, B.M. Elliott, J. Ishmael, J. Odum, J.D. Tugwood, S. Kettle, and I.F. Purchase Mechanistically-based human hazard assessment of peroxisome proliferator-induced hepatocarcinogenesis Hum. Exp. Toxicol. 13 Suppl. 2 1994 S1 S117
33. P.B. Lazarow, and C. De Duve A fatty acyl-CoA oxidizing system in rat liver peroxisomes; enhancement by clofibrate, a hypolipidemic drug Proc. Natl. Acad. Sci. U. S. A. 73 1976 2043 2046
34. J.K. Reddy, and R. Chu Peroxisome proliferator-induced pleiotropic responses: pursuit of a phenomenon Ann. N. Y. Acad. Sci. 804 1996 176 201
35. W.M. Kluwe, E.E. McConnell, J.E. Huff, J.K. Haseman, J.F. Douglas, and W.V. Hartwell Carcinogenicity testing of phthalate esters and related compounds by the National Toxicology Program and the National Cancer Institute Environ. Health Perspect. 45 1982 129 133
36. R.M. David, M.R. Moore, M.A. Cifone, D.C. Finney, and D. Guest Chronic peroxisome proliferation and hepatomegaly associated with the hepatocellular tumorigenesis of di(2-ethylhexyl)phthalate and the effects of recovery Toxicol. Sci. 50 1999 195 205
37. J.R. Warren, V.F. Simmon, and J.K. Reddy Properties of hypolipidemic peroxisome proliferators in the lymphocyte [3H]thymidine and Salmonella mutagenesis assays Cancer Res. 40 1980 36 41
38. M.S. Rao, and J.K. Reddy Hepatocarcinogenesis of peroxisome proliferators Ann. N. Y. Acad. Sci. 804 1996 573 587
39. P. Misra, N. Viswakarma, and J.K. Reddy Peroxisome proliferator-activated receptor-alpha signaling in hepatocarcinogenesis Subcell. Biochem. 69 2013 77 99
40. K. Schoonjans, M. Watanabe, H. Suzuki, A. Mahfoudi, G. Krey, W. Wahli, P. Grimaldi, B. Staels, T. Yamamoto, and J. Auwerx Induction of the acyl-coenzyme A synthetase gene by fibrates and fatty acids is mediated by a peroxisome proliferator response element in the C promoter J. Biol. Chem. 270 1995 19269 19276
41. S.J. Steinberg, J. Morgenthaler, A.K. Heinzer, K.D. Smith, and P.A. Watkins Very long-chain acyl-CoA synthetases. Human "bubblegum" represents a new family of proteins capable of activating very long-chain fatty acids J. Biol. Chem. 275 2000 35162 35169
42. G.P. Mannaerts, and P.P. van Veldhoven Functions and organization of peroxisomal beta-oxidation Ann. N. Y. Acad. Sci. 804 1996 99 115
43. C. Qi, Y. Zhu, J. Pan, N. Usuda, N. Maeda, A.V. Yeldandi, M.S. Rao, T. Hashimoto, and J.K. Reddy Absence of spontaneous peroxisome proliferation in enoyl-CoA hydratase/L-3-hydroxyacyl-CoA dehydrogenase-deficient mouse liver. Further support for the role of fatty acyl CoA oxidase in PPARalpha ligand metabolism J. Biol. Chem. 274 1999 15775 15780
44. S. Huang, P.P. Van Veldhoven, F. Vanhoutte, G. Parmentier, H.J. Eyssen, and G.P. Mannaerts Alpha-oxidation of 3-methyl-substituted fatty acids in rat liver Arch. Biochem. Biophys. 296 1992 214 223
45. J.M. Brandt, F. Djouadi, and D.P. Kelly Fatty acids activate transcription of the muscle carnitine palmitoyltransferase I gene in cardiac myocytes via the peroxisome proliferator-activated receptor alpha J. Biol. Chem. 273 1998 23786 23792
46. I.V. Perevoshchikova, C.L. Quinlan, A.L. Orr, A.A. Gerencser, and M.D. Brand Sites of superoxide and hydrogen peroxide production during fatty acid oxidation in rat skeletal muscle mitochondria Free Radic. Biol. Med. 61C 2013 298 309
47. L.A. Sena, and N.S. Chandel Physiological roles of mitochondrial reactive oxygen species Mol. Cell 48 2012 158 167
48. S.M. Houten, S. Denis, C.A. Argmann, Y. Jia, S. Ferdinandusse, J.K. Reddy, and R.J. Wanders Peroxisomal L-bifunctional enzyme (Ehhadh) is essential for the production of medium-chain dicarboxylic acids J. Lipid Res. 53 2012 1296 1303
49. S. Ferdinandusse, S. Denis, C.W. Van Roermund, R.J. Wanders, and G. Dacremont Identification of the peroxisomal beta-oxidation enzymes involved in the degradation of long-chain dicarboxylic acids J. Lipid Res. 45 2004 1104 1111
50. J. Huang, J. Borensztajn, and J. Reddy Hepatic lipid metabolism S.P.S. Monga, Molecular Pathology of Liver Diseases 2011 Springer US 133 146
51. J. Ding, U. Loizides-Mangold, G. Rando, V. Zoete, O. Michielin, Janardan K. Reddy, W. Wahli, H. Riezman, and B. Thorens The peroxisomal enzyme L-PBE is required to prevent the dietary toxicity of medium-chain fatty acids Cell Rep. 5 1 2013 248 258
52. J.K. Reddy, R.L. Jirtle, T.K. Watanabe, N.K. Reddy, G. Michalopoulos, and S.A. Qureshi Response of hepatocytes transplanted into syngeneic hosts and heterotransplanted into athymic nude mice to peroxisome proliferators Cancer Res. 44 1984 2582 2589
53. M.S. Rao, S. Thorgeirsson, M.K. Reddy, N.D. Lalwani, R.E. Evarts, M.I. Usman, B. Singh, and J.K. Reddy Induction of peroxisome proliferation in hepatocytes transplanted into the anterior chamber of the eye. A model system for the evaluation of xenobiotic-induced effects Am. J. Pathol. 124 1986 519 527
54. Y. Zhu, K. Alvares, Q. Huang, M.S. Rao, and J.K. Reddy Cloning of a new member of the peroxisome proliferator-activated receptor gene family from mouse liver J. Biol. Chem. 268 1993 26817 26820
55. S.J. Bensinger, and P. Tontonoz Integration of metabolism and inflammation by lipid-activated nuclear receptors Nature 454 2008 470 477
56. J.M. Peters, R.C. Cattley, and F.J. Gonzalez Role of PPAR alpha in the mechanism of action of the nongenotoxic carcinogen and peroxisome proliferator Wy-14,643 Carcinogenesis 18 1997 2029 2033
57. T. Hays, I. Rusyn, A.M. Burns, M.J. Kennett, J.M. Ward, F.J. Gonzalez, and J.M. Peters Role of peroxisome proliferator-activated receptor-alpha (PPARalpha) in bezafibrate-induced hepatocarcinogenesis and cholestasis Carcinogenesis 26 2005 219 227
58. S.A. Kliewer, K. Umesono, D.J. Noonan, R.A. Heyman, and R.M. Evans Convergence of 9-cis retinoic acid and peroxisome proliferator signalling pathways through heterodimer formation of their receptors Nature 358 1992 771 774
59. S. Yu, and J.K. Reddy Transcription coactivators for peroxisome proliferator-activated receptors Biochim. Biophys. Acta 1771 2007 936 951
60. Y. Jia, C. Qi, P. Kashireddi, S. Surapureddi, Y.J. Zhu, M.S. Rao, D. Le Roith, P. Chambon, F.J. Gonzalez, and J.K. Reddy Transcription coactivator PBP, the peroxisome proliferator-activated receptor (PPAR)-binding protein, is required for PPARalpha-regulated gene expression in liver J. Biol. Chem. 279 2004 24427 24434
61. W.S. Cook, A.V. Yeldandi, M.S. Rao, T. Hashimoto, and J.K. Reddy Less extrahepatic induction of fatty acid beta-oxidation enzymes by PPAR alpha Biochem. Biophys. Res. Commun. 278 2000 250 257
62. M. Fidaleo Human health risk assessment for peroxisome proliferators: more than 30 years of research Exp. Toxicol. Pathol. 61 2009 215 221
63. W.C. Roberts Safety of fenofibrate-US and worldwide experience Cardiology 76 1989 169 179
64. J.K. Reddy, N.D. Lalwani, S.A. Qureshi, M.K. Reddy, and C.M. Moehle Induction of hepatic peroxisome proliferation in nonrodent species, including primates Am. J. Pathol. 114 1984 171 183
65. N.D. Lalwani, M.K. Reddy, S. Ghosh, S.D. Barnard, J.A. Molello, and J.K. Reddy Induction of fatty acid beta-oxidation and peroxisome proliferation in the liver of rhesus monkeys by DL-040, a new hypolipidemic agent Biochem. Pharmacol. 34 1985 3473 3482
66. D.J. Hoivik, C.W. Qualls Jr., R.C. Mirabile, N.F. Cariello, C.L. Kimbrough, H.M. Colton, S.P. Anderson, M.J. Santostefano, R.J. Morgan, R.R. Dahl, A.R. Brown, Z. Zhao, P.N. Mudd Jr., W.B. Oliver Jr., H.R. Brown, and R.T. Miller Fibrates induce hepatic peroxisome and mitochondrial proliferation without overt evidence of cellular proliferation and oxidative stress in cynomolgus monkeys Carcinogenesis 25 2004 1757 1769
67. S. Satake, C. Nakamura, Y. Minamide, S. Kudo, H. Maeda, Y. Chihaya, Y. Kamimura, H. Miyajima, J. Sasaki, M. Goryo, and K. Okada Effect of a large dose of di (2-ethylhexyl) phthalate (DEHP) on hepatic peroxisome in cynomolgus monkeys (Macaca fascicularis) J. Toxicol. Pathol. 23 2010 75 83
68. B.J. Blaauboer, C.W. van Holsteijn, R. Bleumink, W.C. Mennes, F.N. van Pelt, S.H. Yap, J.F. van Pelt, A.A. van Iersel, A. Timmerman, and B.P. Schmid The effect of beclobric acid and clofibric acid on peroxisomal beta-oxidation and peroxisome proliferation in primary cultures of rat, monkey and human hepatocytes Biochem. Pharmacol. 40 1990 521 528
69. P. Bentley, I. Calder, C. Elcombe, P. Grasso, D. Stringer, and H.J. Wiegand Hepatic peroxisome proliferation in rodents and its significance for humans Food Chem. Toxicol. 31 1993 857 907
70. M. Hanefeld, C. Kemmer, and E. Kadner Relationship between morphological changes and lipid-lowering action of p-chlorphenoxyisobutyric acid (CPIB) on hepatic mitochondria and peroxisomes in man Atherosclerosis 46 1983 239 246
71. A.E. Ganning, A. Elhammer, U. Brunk, and G. Dallner Effect of prolonged phthalate ester administration on rat liver Acta Chem. Scand. 39 1985 319 322
72. A.E. Ganning, U. Brunk, and G. Dallner Phthalate esters and their effect on the liver Hepatology 4 1984 541 547
73. S. Yu, W.Q. Cao, P. Kashireddy, K. Meyer, Y. Jia, D.E. Hughes, Y. Tan, J. Feng, A.V. Yeldandi, M.S. Rao, R.H. Costa, F.J. Gonzalez, and J.K. Reddy Human peroxisome proliferator-activated receptor alpha (PPARalpha) supports the induction of peroxisome proliferation in PPARalpha-deficient mouse liver J. Biol. Chem. 276 2001 42485 42491
74. K. Morimura, C. Cheung, J.M. Ward, J.K. Reddy, and F.J. Gonzalez Differential susceptibility of mice humanized for peroxisome proliferator-activated receptor alpha to Wy-14,643-induced liver tumorigenesis Carcinogenesis 27 2006 1074 1080
75. K.Z. Guyton, W.A. Chiu, T.F. Bateson, J. Jinot, C.S. Scott, R.C. Brown, and J.C. Caldwell A reexamination of the PPAR-alpha activation mode of action as a basis for assessing human cancer risks of environmental contaminants Environ. Health Perspect. 117 2009 1664 1672
76. J.M. Peters, Y.M. Shah, and F.J. Gonzalez The role of peroxisome proliferator-activated receptors in carcinogenesis and chemoprevention Nat. Rev. Cancer 12 2012 181 195
77. F.J. Gonzalez, and Y.M. Shah PPARalpha: mechanism of species differences and hepatocarcinogenesis of peroxisome proliferators Toxicology 246 2008 2 8
78. C.Y. Fan, J. Pan, N. Usuda, A.V. Yeldandi, M.S. Rao, and J.K. Reddy Steatohepatitis, spontaneous peroxisome proliferation and liver tumors in mice lacking peroxisomal fatty acyl-CoA oxidase. Implications for peroxisome proliferator-activated receptor alpha natural ligand metabolism J. Biol. Chem. 273 1998 15639 15645
79. C.N. Palmer, M.H. Hsu, K.J. Griffin, J.L. Raucy, and E.F. Johnson Peroxisome proliferator activated receptor-alpha expression in human liver Mol. Pharmacol. 53 1998 14 22
80. A. Boveris, and E. Cadenas Mitochondrial production of hydrogen peroxide regulation by nitric oxide and the role of ubisemiquinone IUBMB Life 50 2000 245 250
81. B. Poole Diffusion effects in the metabolism of hydrogen peroxide by rat liver peroxisomes J. Theor. Biol. 51 1975 149 167
82. M.R. Nemali, M.K. Reddy, N. Usuda, P.G. Reddy, L.D. Comeau, M.S. Rao, and J.K. Reddy Differential induction and regulation of peroxisomal enzymes: predictive value of peroxisome proliferation in identifying certain nonmutagenic carcinogens Toxicol. Appl. Pharmacol. 97 1989 72 87
83. I. Rusyn, S. Asakura, B. Pachkowski, B.U. Bradford, M.F. Denissenko, J.M. Peters, S.M. Holland, J.K. Reddy, M.L. Cunningham, and J.A. Swenberg Expression of base excision DNA repair genes is a sensitive biomarker for in vivo detection of chemical-induced chronic oxidative stress: identification of the molecular source of radicals responsible for DNA damage by peroxisome proliferators Cancer Res. 64 2004 1050 1057
84. J.K. Reddy, N.D. Lalwani, M.K. Reddy, and S.A. Qureshi Excessive accumulation of autofluorescent lipofuscin in the liver during hepatocarcinogenesis by methyl clofenapate and other hypolipidemic peroxisome proliferators Cancer Res. 42 1982 259 266
85. C.S. Giometti, X. Liang, S.L. Tollaksen, D.B. Wall, D.M. Lubman, V. Subbarao, and M.S. Rao Mouse liver selenium-binding protein decreased in abundance by peroxisome proliferators Electrophoresis 21 2000 2162 2169
86. H. Kasai, Y. Okada, S. Nishimura, M.S. Rao, and J.K. Reddy Formation of 8-hydroxydeoxyguanosine in liver DNA of rats following long-term exposure to a peroxisome proliferator Cancer Res. 49 1989 2603 2605
87. J.H. Kim, A. Qu, J.K. Reddy, B. Gao, and F.J. Gonzalez Hepatic oxidative stress activates the Gadd45b gene via degradation of the transcriptional repressor STAT3 Hepatology Aug 12, 2013 10.1002/hep.26683 [Epub ahead of print]
88. H.M. Tyra, D.R. Spitz, and D.T. Rutkowski Inhibition of fatty acid oxidation enhances oxidative protein folding and protects hepatocytes from endoplasmic reticulum stress Mol. Biol. Cell 23 2012 811 819
89. 2-generating peroxisomal fatty acyl-CoA oxidase Proc. Natl. Acad. Sci. U. S. A. 92 1995 7080 7084
90. 2-generating peroxisomal urate oxidase Cancer Res. 56 1996 4846 4852
91. M.S. Rao, N.D. Lalwani, T.K. Watanabe, and J.K. Reddy Inhibitory effect of antioxidants ethoxyquin and 2(3)-tert-butyl-4-hydroxyanisole on hepatic tumorigenesis in rats fed ciprofibrate, a peroxisome proliferator Cancer Res. 44 1984 1072 1076
92. C.C. Benz, and C. Yau Ageing, oxidative stress and cancer: paradigms in parallax Nat. Rev. Cancer 8 2008 875 879
93. E.J. Gallagher, and D. LeRoith Epidemiology and molecular mechanisms tying obesity, diabetes, and the metabolic syndrome with cancer Diabetes Care 36 Suppl. 2 2013 S233 S239
94. E. Cayama, H. Tsuda, D.S. Sarma, and E. Farber Initiation of chemical carcinogenesis requires cell proliferation Nature 275 1978 60 62
95. J.K. Reddy, M.S. Rao, D.L. Azarnoff, and S. Sell Mitogenic and carcinogenic effects of a hypolipidemic peroxisome proliferator, [4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio]acetic acid (Wy-14, 643), in rat and mouse liver Cancer Res. 39 1979 152 161
96. A.V. Yeldandi, M. Milano, V. Subbarao, J.K. Reddy, and M.S. Rao Evaluation of liver cell proliferation during ciprofibrate-induced hepatocarcinogenesis Cancer Lett. 47 1989 21 27
97. Y.M. Shah, K. Morimura, Q. Yang, T. Tanabe, M. Takagi, and F.J. Gonzalez Peroxisome proliferator-activated receptor alpha regulates a microRNA-mediated signaling cascade responsible for hepatocellular proliferation Mol. Cell. Biol. 27 2007 4238 4247
98. E.J. Park, J.H. Lee, G.Y. Yu, G. He, S.R. Ali, R.G. Holzer, C.H. Osterreicher, H. Takahashi, and M. Karin Dietary and genetic obesity promote liver inflammation and tumorigenesis by enhancing IL-6 and TNF expression Cell 140 2010 197 208
99. S. Toffanin, S.L. Friedman, and J.M. Llovet Obesity, inflammatory signaling, and hepatocellular carcinoma-an enlarging link Cancer Cell 17 2010 115 117
100. I.R. Lanza, P. Zabielski, K.A. Klaus, D.M. Morse, C.J. Heppelmann, H.R. Bergen 3rd, S. Dasari, S. Walrand, K.R. Short, M.L. Johnson, M.M. Robinson, J.M. Schimke, D.R. Jakaitis, Y.W. Asmann, Z. Sun, and K.S. Nair Chronic caloric restriction preserves mitochondrial function in senescence without increasing mitochondrial biogenesis Cell Metab. 16 2012 777 788
101. M.M. Masternak, K.A. Al-Regaiey, M.M. Del Rosario Lim, M.S. Bonkowski, J.A. Panici, G.K. Przybylski, and A. Bartke Caloric restriction results in decreased expression of peroxisome proliferator-activated receptor superfamily in muscle of normal and long-lived growth hormone receptor/binding protein knockout mice J. Gerontol. 60 2005 1238 1245
102. S. Kersten, J. Seydoux, J.M. Peters, F.J. Gonzalez, B. Desvergne, and W. Wahli Peroxisome proliferator-activated receptor alpha mediates the adaptive response to fasting J. Clin. Invest. 103 1999 1489 1498
103. T. Hashimoto, W.S. Cook, C. Qi, A.V. Yeldandi, J.K. Reddy, and M.S. Rao Defect in peroxisome proliferator-activated receptor alpha-inducible fatty acid oxidation determines the severity of hepatic steatosis in response to fasting J. Biol. Chem. 275 2000 28918 28928
104. T. Aoyama, J.M. Peters, N. Iritani, T. Nakajima, K. Furihata, T. Hashimoto, and F.J. Gonzalez Altered constitutive expression of fatty acid-metabolizing enzymes in mice lacking the peroxisome proliferator-activated receptor alpha (PPARalpha) J. Biol. Chem. 273 1998 5678 5684
105. Y. Ito, O. Yamanoshita, N. Asaeda, Y. Tagawa, C.H. Lee, T. Aoyama, G. Ichihara, K. Furuhashi, M. Kamijima, F.J. Gonzalez, and T. Nakajima Di(2-ethylhexyl)phthalate induces hepatic tumorigenesis through a peroxisome proliferator-activated receptor alpha-independent pathway J. Occup. Health 49 2007 172 182
106. Di(2-ethylhexyl) Phthalate, IARC Monographs on the Evaluation of Carcinogenic Risks to Humans vol. 101 2012 World Health Organization, International Agency for Research on Cancer 149 260
107. J.E. Klaunig, M.A. Babich, K.P. Baetcke, J.C. Cook, J.C. Corton, R.M. David, J.G. DeLuca, D.Y. Lai, R.H. McKee, J.M. Peters, R.A. Roberts, and P.A. Fenner-Crisp PPARalpha agonist-induced rodent tumors: modes of action and human relevance Crit. Rev. Toxicol. 33 2003 655 780
108. T. Hashimoto, T. Fujita, N. Usuda, W. Cook, C. Qi, J.M. Peters, F.J. Gonzalez, A.V. Yeldandi, M.S. Rao, and J.K. Reddy Peroxisomal and mitochondrial fatty acid beta-oxidation in mice nullizygous for both peroxisome proliferator-activated receptor alpha and peroxisomal fatty acyl-CoA oxidase. Genotype correlation with fatty liver phenotype J. Biol. Chem. 274 1999 19228 19236
109. K. Matsumoto, J. Huang, N. Viswakarma, L. Bai, Y. Jia, Y.T. Zhu, G. Yang, J. Borensztajn, M.S. Rao, Y.J. Zhu, and J.K. Reddy Transcription coactivator PBP/MED1-deficient hepatocytes are not susceptible to diethylnitrosamine-induced hepatocarcinogenesis in the mouse Carcinogenesis 31 2010 318 325
110. K. Matsumoto, S. Yu, Y. Jia, M.R. Ahmed, N. Viswakarma, J. Sarkar, P.V. Kashireddy, M.S. Rao, W. Karpus, F.J. Gonzalez, and J.K. Reddy Critical role for transcription coactivator peroxisome proliferator-activated receptor (PPAR)-binding protein/TRAP220 in liver regeneration and PPARalpha ligand-induced liver tumor development J. Biol. Chem. 282 2007 17053 17060
111. C.V. Dang Links between metabolism and cancer Genes Dev. 26 2012 877 890